John Cox, Director at REPLIGEN CORP (RGEN), sold 10,000 shares at $93.39 ($934K) on 2020-03-04, disclosed to the SEC on 2020-03-05.
Open-market sale of $934k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |